Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-26 COOK DAVID N Exercise or conversion · RESTRICTED STOCK UNITS −5,000 20,000
2018-01-24 Pomerantz Roger President and CEO Exercise or conversion +40,241 $0.71 $29K 324,537
2018-01-24 Pomerantz Roger President and CEO Exercise or conversion · Stock Option (right to buy) −40,241 911,441
2017-12-19 Aunins John G. Exercise or conversion +5,000 197,125
2017-12-19 Aunins John G. Sale −1,623 $10.14 $16K 195,502
2017-12-19 Aunins John G. Chief Technology Officer & EVP Exercise or conversion +5,000 61,060
2017-12-19 Aunins John G. Chief Technology Officer & EVP Sale −1,623 $10.14 $16K 59,437
2017-12-19 Aunins John G. Chief Technology Officer & EVP Exercise or conversion · Restricted Stock Units −5,000 15,000
2017-07-18 Pomerantz Roger President and CEO Exercise or conversion +100,604 $0.71 $71K 284,296
2017-07-18 Pomerantz Roger President and CEO Exercise or conversion · Stock Option (right to buy) −100,604 951,682
2017-07-07 Dere Willard H Director Grant or award · Stock Option (right to buy) +30,000 30,000
2017-06-20 Kender Richard N Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-20 AFEYAN NOUBAR Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-20 Graves Kurt Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-20 Kim Lorence H. Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-20 Ausiello Dennis A Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-20 Behar Gregory Director Grant or award · Stock Option (right to buy) +15,000 15,000
2017-06-19 Aunins John G. Chief Technology Officer & EVP Grant or award · Restricted Stock Units +20,000 20,000
2017-01-26 DesRosier Thomas Chief Legal Officer and EVP Grant or award · Stock Option (right to buy) +60,000 60,000
2017-01-26 DesRosier Thomas Chief Legal Officer and EVP Grant or award · Restricted Stock Units +50,000 50,000

Page 30 of 34 · 662 trades